热门资讯> 正文
Bluejay Diagnostics通过认购权交易筹集370万美元后股价暴跌
2025-04-08 05:29
- Bluejay Diagnostics (NASDAQ:BJDX) has entered into an agreement with institutional investors to purchase shares of common stock of the company for cash.
- The investors agreed to exercise the existing warrants to purchase about 1M shares of common stock at a reduced exercise price of $3.42 per share, resulting in gross proceeds of approximately $3.7M.
- BJDX -26.66% after hours to $5.5.
- In consideration for the exercise of the existing warrants for cash, the investors received new warrants to purchase up to an aggregate of around 1M shares of common stock. The new warrants are exercisable immediately at an exercise price of $3.42 per common share and will expire five years from the issuance date.
- Source: Press Release
More on Bluejay Diagnostics
- Financial information for Bluejay Diagnostics
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
